January Investor Deep Dives: MyRounding & Fluonic

When
Wednesday, January 14, 2015
1:00 PM - 5:30 PM
Location
Holland & Hart Denver, 555 17th Street #3200, Denver, CO 80202
Spaces left
15

Registration

Investor or Fund Manager (Member)
Investor or Fund Manager (non-member)

Registration is closed

Investor Deep Dives

JANUARY 2015

MyRounding & Fluonic

Date: Wednesday, January 14th

1-3pm & 3:30-5:30pm

Location: Holland & Hart Denver

555 17th Street #3200

Denver, CO 80202

Schedule:

1:00 - 3:00 - MyRounding
3:00 - 3:30 - Break
3:30 - 5:30 - Fluonic

A patient spends less than 2% of their stay with their doctor. The other 98% is spent interacting with nurses, staff, administrators. Most hospitals leaders have no visibility to the issues that arise during the patient stay. We provide a mobile, real-time issue capture system that scales across departments, hospitals and systems. In addition, the financial incentives via the ACA for high-performers has accelerated adoption of our product.

Please see MyRounding's Gust profile page for more info: https://gust.com/deals/615642

Fluonic is a medical digital health care flow monitoring and control company with a primary focus on infusion applications. Fluonic has a new generation of infusion devices information systems that will improve patients' compliance and safety while reducing costs. The company is deploying its proprietary disposable flow sensor to make the first-in-kind infusion system capable of monitoring the infusion rate that the patient actually receives.

Infusion is used in > 90% of hospital treatments, with>$10B sales per year. Yet infusion systems suffer from an alarming limitation: they are unable to determine the drug flowing through them, flow they create or that flow is entering the patient. This limitation causes > 7,000 deaths and > 1.5M adverse events/year costing hospitals > $4B annually. Fluonic solves this problem and transmits this information wirelessly to health care providers.

Please see Fluonic's Gust profile page for more https://gust.com/deals/515589

-----------------------

The purpose of this meeting is to meet face-to-face with the company CEO and leadership in order to get crucial questions answered. The deep dive will take place at Holland & Hart Denver and will cover all the major due diligence questions such as IP, competition, leadership, funding strategy, exit strategy, use of funds, milestones, etc.

The format for the Deep Dive will be to spend 1:00 with each company, then have 20 minutes of private investor discussion followed by 10 minutes of follow-up questions for team members.

________________________________________________

Newcomers are welcome regardless of whether they are experienced Angels or if they are just curious. There is no requirement to invest and each investor makes personal decisions on each deal.

To attend, you must be an accredited investor (net worth of at least one million US dollars, not including the value of one’s primary residence, or have made at least $200,000 each year for the last two years [or $300,000 together with his or her spouse if married] and have the expectation to make the same amount this year). We do not require a minimum investment.